HGF and neoplasm: Moreover, NAC-HCPS significantly inhibited tumor growth and vascularization of subcutaneously implanted 3LL, an effect likely related to its ability to inhibit the endothelial cell growth stimulated by VEGF165, FGF2, or HGF.